MAYNE PHARMA INC FDA Approval ANDA 089007

ANDA 089007

MAYNE PHARMA INC

FDA Drug Application

Application #089007

Application Sponsors

ANDA 089007MAYNE PHARMA INC

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL325MG;50MG;40MG0BUTALBITAL, ACETAMINOPHEN AND CAFFEINEACETAMINOPHEN; BUTALBITAL; CAFFEINE

FDA Submissions

ORIG1AP1986-03-17
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1986-05-19
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1988-03-29
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1988-03-29
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1988-03-29
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1988-03-29
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1988-03-29
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1988-03-29
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1988-11-03
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1987-06-02
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1992-06-04
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1988-03-29
LABELING; LabelingSUPPL14AP1988-09-20
LABELING; LabelingSUPPL15AP1988-10-26
LABELING; LabelingSUPPL16AP1988-10-26
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1988-11-03
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1988-11-03
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1989-04-14
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1990-12-31
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1990-12-31
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1990-12-31
LABELING; LabelingSUPPL23AP1990-12-31
LABELING; LabelingSUPPL24AP1991-12-03
LABELING; LabelingSUPPL26AP1993-10-15
MANUF (CMC); Manufacturing (CMC)SUPPL27AP1995-02-08
MANUF (CMC); Manufacturing (CMC)SUPPL28AP1995-09-15
LABELING; LabelingSUPPL29AP1996-03-22
MANUF (CMC); Manufacturing (CMC)SUPPL30AP1998-04-06
LABELING; LabelingSUPPL31AP2001-03-23
MANUF (CMC); Manufacturing (CMC)SUPPL32AP1998-04-06
MANUF (CMC); Manufacturing (CMC)SUPPL33AP1998-04-06
MANUF (CMC); Manufacturing (CMC)SUPPL34AP1998-04-06
MANUF (CMC); Manufacturing (CMC)SUPPL35AP1998-07-31
MANUF (CMC); Manufacturing (CMC)SUPPL36AP2001-03-28
MANUF (CMC); Manufacturing (CMC)SUPPL37AP2002-08-13
LABELING; LabelingSUPPL38AP2003-05-08
LABELING; LabelingSUPPL43AP2011-06-22
LABELING; LabelingSUPPL44AP2013-10-18STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL27Null0
SUPPL28Null0
SUPPL30Null0
SUPPL32Null0
SUPPL33Null0
SUPPL34Null0
SUPPL35Null0
SUPPL36Null0
SUPPL37Null0
SUPPL43Null7
SUPPL44Null15

TE Codes

001PrescriptionAA

CDER Filings

MAYNE PHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 89007
            [companyName] => MAYNE PHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","activeIngredients":"ACETAMINOPHEN; BUTALBITAL; CAFFEINE","strength":"325MG;50MG;40MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE","submission":"ACETAMINOPHEN; BUTALBITAL; CAFFEINE","actionType":"325MG;50MG;40MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.